1.40 (-%)
As of Oct 31, 2024
Source:
Allarity is a clinical-stage, precision medicine pharmaceutical company actively advancing in-licensed oncology therapeutics for patients with difficult-to-treat cancers leveraging Allarity’s core technology, the Drug Response Predictor platform, to identify the patients most likely to derive clinical benefit from any individual therapeutic.
Country | United States |
Headquarters | boston, massachusetts |
Phone Number | (401) 426-4664 |
Industry | manufacturing |
CEO | Thomas Jensen |
Website | www.allarity.com |